MAPT and Alzheimer disease: Indeed, several studies have demonstrated that intranasal insulin treatment improves cognitive performance, attenuates hyperphosphorylation of tau protein, as well as ameliorates microglial activation in individuals with an early stage of AD [81,82,83,84].